chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sick for day and a half; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick for day and a half) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ILLNESS (sick for day and a half). At the time of the report, ILLNESS (sick for day and a half) outcome was unknown. Not Provided          No concomitant medications and treatment reported.    This case was linked to MODERNATX, INC.-MOD-2021-068773 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-068773:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Neck pain, Paraesthesia, Vaccination site pain
Clinical narrative: severe neck and shoulder pain; severe headaches; severe neck and shoulder pain; Pain at injection site; Swelling at injection site; Tingling sensation in the face (Eyelid, jaws and lips); This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation in the face (Eyelid, jaws and lips)), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE SWELLING (Swelling at injection site), HEADACHE (severe headaches) and NECK PAIN (severe neck and shoulder pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 04-Apr-2021, the patient experienced PARAESTHESIA (Tingling sensation in the face (Eyelid, jaws and lips)).   On 05-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling at injection site).   On an unknown date, the patient experienced HEADACHE (severe headaches), NECK PAIN (severe neck and shoulder pain) and ARTHRALGIA (severe neck and shoulder pain).   At the time of the report, PARAESTHESIA (Tingling sensation in the face (Eyelid, jaws and lips)), HEADACHE (severe headaches), NECK PAIN (severe neck and shoulder pain) and ARTHRALGIA (severe neck and shoulder pain) had resolved and VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   She is concerned about the tingling sensation and she wants to know if that is a common adverse event.Concomitant medications were not reported.  Treatment details include ibuprofen for symptom relieve. She consents to follow up.   This case was linked to MOD-2021-139354  (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: new information received
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: severe neck and shoulder pain; severe headaches; severe neck and shoulder pain; Pain at injection site; Swelling at injection site; Tingling sensation in the face (Eyelid, jaws and lips); This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation in the face (Eyelid, jaws and lips)), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE SWELLING (Swelling at injection site), HEADACHE (severe headaches) and NECK PAIN (severe neck and shoulder pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 04-Apr-2021, the patient experienced PARAESTHESIA (Tingling sensation in the face (Eyelid, jaws and lips)).   On 05-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling at injection site).   On an unknown date, the patient experienced HEADACHE (severe headaches), NECK PAIN (severe neck and shoulder pain) and ARTHRALGIA (severe neck and shoulder pain).   At the time of the report, PARAESTHESIA (Tingling sensation in the face (Eyelid, jaws and lips)), HEADACHE (severe headaches), NECK PAIN (severe neck and shoulder pain) and ARTHRALGIA (severe neck and shoulder pain) had resolved and VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   She is concerned about the tingling sensation and she wants to know if that is a common adverse event.Concomitant medications were not reported.  Treatment details include ibuprofen for symptom relieve. She consents to follow up.   This case was linked to MOD-2021-139354  (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: new information received
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old received the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received the vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  Treatment details not provided. Concomitant medications were not reported.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site inflammation, Vaccination site irritation, Vaccination site warmth
Clinical narrative: Local fever sensation at the vaccination site; Irritation at the vaccination site; Inflammation at the vaccination site; Redness at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Local fever sensation at the vaccination site), VACCINATION SITE IRRITATION (Irritation at the vaccination site), VACCINATION SITE INFLAMMATION (Inflammation at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Local fever sensation at the vaccination site), VACCINATION SITE IRRITATION (Irritation at the vaccination site), VACCINATION SITE INFLAMMATION (Inflammation at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site). At the time of the report, VACCINATION SITE WARMTH (Local fever sensation at the vaccination site), VACCINATION SITE IRRITATION (Irritation at the vaccination site), VACCINATION SITE INFLAMMATION (Inflammation at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: chills; body aches; feeling tired; felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN (body aches), FATIGUE (feeling tired) and FATIGUE (felt a little tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 immunisation.     Concurrent medical conditions included Drug allergy (sulfa allergy).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced FATIGUE (felt a little tired). On 06-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (chills), PAIN (body aches) and FATIGUE (feeling tired). At the time of the report, CHILLS (chills), PAIN (body aches), FATIGUE (feeling tired) and FATIGUE (felt a little tired) had not resolved.            No concomitant medication was available. No treatment Medication was available.  Action taken with mRNA-1273 in response to events were not applicable.   This case was linked to MOD-2021-068474 (E2B Linked Report).; Sender's Comments:  MOD-2021-068474:
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for an unknown indication.    No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 25-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-068495 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068495:Second dose
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Gingival blister, Gingivitis, Headache
Clinical narrative: Right jaw pain; Poping, locking, chewing, opening mouth and yawning problems; Swollen gums; Swollen lymph nodes; Fatigue; Fever; Chills; Headache; Gums/blisters; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL BLISTER (Gums/blisters), PAIN IN JAW (Right jaw pain), TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems), GINGIVITIS (Swollen gums) and LYMPHADENOPATHY (Swollen lymph nodes) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0088B21-21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced GINGIVAL BLISTER (Gums/blisters), GINGIVITIS (Swollen gums), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). On 04-Apr-2021, the patient experienced PAIN IN JAW (Right jaw pain) and TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems). On 09-Apr-2021, GINGIVAL BLISTER (Gums/blisters), GINGIVITIS (Swollen gums), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, PAIN IN JAW (Right jaw pain) and TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-245544, MOD-2021-245544 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Updated reporter information, Added patient demographics, Events were added and event outcome was updated.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in jaw, Pyrexia, Temporomandibular joint syndrome
Clinical narrative: Right jaw pain; Poping, locking, chewing, opening mouth and yawning problems; Swollen gums; Swollen lymph nodes; Fatigue; Fever; Chills; Headache; Gums/blisters; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL BLISTER (Gums/blisters), PAIN IN JAW (Right jaw pain), TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems), GINGIVITIS (Swollen gums) and LYMPHADENOPATHY (Swollen lymph nodes) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0088B21-21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced GINGIVAL BLISTER (Gums/blisters), GINGIVITIS (Swollen gums), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). On 04-Apr-2021, the patient experienced PAIN IN JAW (Right jaw pain) and TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems). On 09-Apr-2021, GINGIVAL BLISTER (Gums/blisters), GINGIVITIS (Swollen gums), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, PAIN IN JAW (Right jaw pain) and TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-245544, MOD-2021-245544 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Updated reporter information, Added patient demographics, Events were added and event outcome was updated.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Photophobia
Clinical narrative: sensitivity to light; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (sensitivity to light) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031b21a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine), Hypertension since 2005, Vitreous floaters since 1990 and Migraine (Ocular,occurs less than twice a year) since 2018. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) from 2005 to an unknown date for Hypertension, MULTIVITAMIN FOR WOMEN from 1988 to an unknown date for an unknown indication.    On 06-Apr-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021 at 9:30 AM, the patient experienced PHOTOPHOBIA (sensitivity to light). On 07-Apr-2021, PHOTOPHOBIA (sensitivity to light) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided.  The patient had similar event in the past during eye dilation by ophthalmologist.   This case was linked to MOD-2021-221194 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up received on 14-JUN-2021. Updated patient demographics, medical history, concomitant medication and event outcome changed from not recovered to recovered with stop date.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of Photophobia, a causal relationship cannot be excluded.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Headache; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified and Muscular dystrophy.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills). On 11-Mar-2021, HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment medication included antibiotics
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site rash, Nasopharyngitis, Pruritus
Clinical narrative: Cold; Red bumps; Itching; a rash on her injection site arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red bumps), PRURITUS (Itching), NASOPHARYNGITIS (Cold) and INJECTION SITE RASH (a rash on her injection site arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced ERYTHEMA (Red bumps), PRURITUS (Itching) and NASOPHARYNGITIS (Cold). On an unknown date, the patient experienced INJECTION SITE RASH (a rash on her injection site arm). At the time of the report, ERYTHEMA (Red bumps) and PRURITUS (Itching) had not resolved and NASOPHARYNGITIS (Cold) and INJECTION SITE RASH (a rash on her injection site arm) had resolved.      No concomitant products were reported.  Treatment information provided included Ibuprofen, Benadryl, Calamine Lotion and vasline   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow-up information received on 17-May-2021. New event added. Outcome of the event cold (nasopharyngitis) changed from not recovered/not resolved to recovered/resolved.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; fever of 101F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101F) and CHILLS (chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.  Concurrent medical conditions included Hypertension and Cholesterol. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and FISH OIL for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-Apr-2021, the patient experienced PYREXIA (fever of 101F) and CHILLS (chills). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, PYREXIA (fever of 101F) was resolving and CHILLS (chills) outcome was unknown.            Other Concomitant medications reported were Blood pressure medication, Cholesterol pill.  Action taken with mRNA-1273 in response to the events were not Applicable.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (fever) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Feb-2021, the patient experienced CHILLS (Chills) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 20-Feb-2021, CHILLS (Chills) and PYREXIA (fever) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-068489 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068489:Dose 1
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Pain in extremity, Sarcopenia
Clinical narrative: Foot pain; stomach pain; started losing muscle mass; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Foot pain), ABDOMINAL PAIN UPPER (stomach pain) and SARCOPENIA (started losing muscle mass) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced SARCOPENIA (started losing muscle mass). On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (Foot pain) and ABDOMINAL PAIN UPPER (stomach pain). At the time of the report, PAIN IN EXTREMITY (Foot pain), ABDOMINAL PAIN UPPER (stomach pain) and SARCOPENIA (started losing muscle mass) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was unknown
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspepsia, Hyperhidrosis, Injection site rash, Nausea
Clinical narrative: pain in legs; stomach burn; severe sweating and ringing in her ears; severe sweating and ringing in her ears; swelling on the arm and a rash on the injection site; dizziness; swelling on the arm and a rash on the injection site; nausea; Soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (severe sweating and ringing in her ears), PAIN IN EXTREMITY (Soreness on her arm), PAIN IN EXTREMITY (pain in legs), PERIPHERAL SWELLING (swelling on the arm and a rash on the injection site) and DIZZINESS (dizziness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included TRIAMCINOLONE ACETONIDE (NASACORT), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), VITAMIN B NOS and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness on her arm). On 01-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling on the arm and a rash on the injection site), DIZZINESS (dizziness), INJECTION SITE RASH (swelling on the arm and a rash on the injection site) and NAUSEA (nausea). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (severe sweating and ringing in her ears). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in legs), DYSPEPSIA (stomach burn) and TINNITUS (severe sweating and ringing in her ears). At the time of the report, HYPERHIDROSIS (severe sweating and ringing in her ears), PAIN IN EXTREMITY (pain in legs), PERIPHERAL SWELLING (swelling on the arm and a rash on the injection site), DYSPEPSIA (stomach burn), TINNITUS (severe sweating and ringing in her ears) and INJECTION SITE RASH (swelling on the arm and a rash on the injection site) outcome was unknown, PAIN IN EXTREMITY (Soreness on her arm) had resolved and DIZZINESS (dizziness) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication include Hydrocortisone cream, Claritin, Dramamine and Pepto Bismol.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Tinnitus
Clinical narrative: pain in legs; stomach burn; severe sweating and ringing in her ears; severe sweating and ringing in her ears; swelling on the arm and a rash on the injection site; dizziness; swelling on the arm and a rash on the injection site; nausea; Soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (severe sweating and ringing in her ears), PAIN IN EXTREMITY (Soreness on her arm), PAIN IN EXTREMITY (pain in legs), PERIPHERAL SWELLING (swelling on the arm and a rash on the injection site) and DIZZINESS (dizziness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included TRIAMCINOLONE ACETONIDE (NASACORT), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), VITAMIN B NOS and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness on her arm). On 01-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling on the arm and a rash on the injection site), DIZZINESS (dizziness), INJECTION SITE RASH (swelling on the arm and a rash on the injection site) and NAUSEA (nausea). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (severe sweating and ringing in her ears). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in legs), DYSPEPSIA (stomach burn) and TINNITUS (severe sweating and ringing in her ears). At the time of the report, HYPERHIDROSIS (severe sweating and ringing in her ears), PAIN IN EXTREMITY (pain in legs), PERIPHERAL SWELLING (swelling on the arm and a rash on the injection site), DYSPEPSIA (stomach burn), TINNITUS (severe sweating and ringing in her ears) and INJECTION SITE RASH (swelling on the arm and a rash on the injection site) outcome was unknown, PAIN IN EXTREMITY (Soreness on her arm) had resolved and DIZZINESS (dizziness) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication include Hydrocortisone cream, Claritin, Dramamine and Pepto Bismol.   Reporter did not allow further contact
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed her second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed her second dose) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer (Currently cancer free from lung cancer.) and Pacemaker insertion (cardiac) (Pacemaker for bradycardia.). Concurrent medical conditions included Hypothyroidism, Blind left eye and COPD (Having COPD and is on oxygen.). Concomitant products included ATENOLOL, CLOPIDOGREL, LEVOTHYROXINE and FUROSEMIDE (LASIX [FUROSEMIDE]) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed her second dose). On 06-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missed her second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products used included atenolol 40 mg once a day, Lasix 40 mg daily, eyedrops orbolamide twice a day, levothyroxine 50 mg once a day, clopidogrel 75 mg once a day, on oxygen.  Treatment medication was not provided by the reporter.  This report refers to a case of Product dose omission issue for mRNA-1273, lot # unkonwn with no associated AEs.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unkonwn with no associated AEs.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pain in extremity
Clinical narrative: Arm a little sore; pregnant patient who was vaccinated in the third trimester; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm a little sore) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient who was vaccinated in the third trimester) in a 33-year-old female patient (para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Mar-2021. On 10-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient who was vaccinated in the third trimester). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm a little sore). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Delivered NOS. She had delivered the baby. On 10-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant patient who was vaccinated in the third trimester) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm a little sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medication information was provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-068523 (E2B Linked Report).; Sender's Comments:  MOD-2021-068523:2nd dose
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: several people got sick after getting 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (several people got sick after getting 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Mar-2021, the patient experienced ILLNESS (several people got sick after getting 2nd dose). At the time of the report, ILLNESS (several people got sick after getting 2nd dose) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  No treatment medication was provided   This case was linked to MOD21-070120,MOD-2021-068974 (E2B Linked Report).; Sender's Comments:  MOD21-070120:Crosslink MOD-2021-068974:Crosslinked
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Fatigue, Herpes virus infection, Pain
Clinical narrative: cold sweats; herpes break out; pain; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Apr-2021 and was forwarded to Moderna on 06-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), HERPES VIRUS INFECTION (herpes break out), COLD SWEAT (cold sweats) and FATIGUE (fatigue) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (pain) and FATIGUE (fatigue). On 23-Mar-2021, the patient experienced HERPES VIRUS INFECTION (herpes break out). On 03-Apr-2021, the patient experienced COLD SWEAT (cold sweats). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes infection, at a dose of UNK dosage form. At the time of the report, PAIN (pain), HERPES VIRUS INFECTION (herpes break out), COLD SWEAT (cold sweats) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Headache, Myalgia
Clinical narrative: diarrhea; slept all day; couldn't eat or drink water; tiredness; body ache; headache; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), SLEEP DISORDER (slept all day), DECREASED APPETITE (couldn't eat or drink water), HEADACHE (headache) and VOMITING (vomiting) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (headache) and VOMITING (vomiting). On 03-Apr-2021, the patient experienced MYALGIA (body ache). On 05-Apr-2021, the patient experienced DIARRHOEA (diarrhea), SLEEP DISORDER (slept all day), DECREASED APPETITE (couldn't eat or drink water) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 03-Apr-2021, MYALGIA (body ache) had resolved. On 05-Apr-2021, DIARRHOEA (diarrhea), SLEEP DISORDER (slept all day), DECREASED APPETITE (couldn't eat or drink water) and FATIGUE (tiredness) had resolved. At the time of the report, HEADACHE (headache) and VOMITING (vomiting) outcome was unknown.            No concomitant medication was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-068534 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068534:crosslinked with first dose
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Vomiting
Clinical narrative: diarrhea; slept all day; couldn't eat or drink water; tiredness; body ache; headache; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), SLEEP DISORDER (slept all day), DECREASED APPETITE (couldn't eat or drink water), HEADACHE (headache) and VOMITING (vomiting) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (headache) and VOMITING (vomiting). On 03-Apr-2021, the patient experienced MYALGIA (body ache). On 05-Apr-2021, the patient experienced DIARRHOEA (diarrhea), SLEEP DISORDER (slept all day), DECREASED APPETITE (couldn't eat or drink water) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 03-Apr-2021, MYALGIA (body ache) had resolved. On 05-Apr-2021, DIARRHOEA (diarrhea), SLEEP DISORDER (slept all day), DECREASED APPETITE (couldn't eat or drink water) and FATIGUE (tiredness) had resolved. At the time of the report, HEADACHE (headache) and VOMITING (vomiting) outcome was unknown.            No concomitant medication was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-068534 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068534:crosslinked with first dose
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site.) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site.). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site.) had resolved. Not Provided          No treatment information was provided.  No concomitant medication was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-068519 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068519:CROSS LINKED WITH DOSE 2
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Vaccination site reaction
Clinical narrative: fever; chills; very bad reaction; very very achy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (very bad reaction), PAIN (very very achy), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (very bad reaction), PAIN (very very achy), PYREXIA (fever) and CHILLS (chills). At the time of the report, VACCINATION SITE REACTION (very bad reaction), PAIN (very very achy), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Vaccination site lymphadenopathy
Clinical narrative: chills in my left and right Arms; lymph nodes in my injection site arm are in pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills in my left and right Arms) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in my injection site arm are in pain) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.  No Medical History information was reported.  On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced CHILLS (chills in my left and right Arms) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in my injection site arm are in pain). At the time of the report, CHILLS (chills in my left and right Arms) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in my injection site arm are in pain) had not resolved.            No treatment information was provided.  No concomitant medication was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles rash; This spontaneous case was reported by a nurse and describes the occurrence of HERPES ZOSTER (Shingles rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced HERPES ZOSTER (Shingles rash). At the time of the report, HERPES ZOSTER (Shingles rash) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Neuralgia, Sciatica
Clinical narrative: Sciatica, back pain shooting down leg; Shingles, rash on right hip working down to buttocks down the front onto groin and leg/ Residual pain; back nerve pain; This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (Sciatica, back pain shooting down leg), HERPES ZOSTER (Shingles, rash on right hip working down to buttocks down the front onto groin and leg/ Residual pain) and NEURALGIA (back nerve pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included Shingrix in 2019. Concurrent medical conditions included Chronic cough since 1991. Concomitant products included PANTOPRAZOLE, FAMOTIDINE, AMLODIPINE and FLUOXETINE for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced NEURALGIA (back nerve pain). On 01-Mar-2021, the patient experienced HERPES ZOSTER (Shingles, rash on right hip working down to buttocks down the front onto groin and leg/ Residual pain). On an unknown date, the patient experienced SCIATICA (Sciatica, back pain shooting down leg). The patient was treated with METHYLPREDNISOLONE (MEDROL DOSEPAK) ongoing since an unknown date for Sciatica, at an unspecified dose and frequency; VALACYCLOVIR [VALACICLOVIR] ongoing since an unknown date for Shingles, at a dose of 1 gram three times a day and GABAPENTIN ongoing since an unknown date for Nerve pain, at an unspecified dose and frequency. At the time of the report, SCIATICA (Sciatica, back pain shooting down leg) and NEURALGIA (back nerve pain) outcome was unknown and HERPES ZOSTER (Shingles, rash on right hip working down to buttocks down the front onto groin and leg/ Residual pain) had not resolved. Not Provided          Treatment information included pain meds and sterioids.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Added relevant medical history (Chronic cough), concomitant medications (Pantoprazole, Famotidine, Amlodipinre, Fluoxetine ). Added lot number of 1st dose of vaccine. The outcome of the event (Shingles) changed (from Resolved to Not resolved).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site inflammation, Vaccination site irritation, Vaccination site warmth
Clinical narrative: Inflammation at the vaccination site; Local fever sensation at the vaccination site; Irritation at the vaccination site; Redness at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflammation at the vaccination site), VACCINATION SITE WARMTH (Local fever sensation at the vaccination site), VACCINATION SITE IRRITATION (Irritation at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 27-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (Inflammation at the vaccination site), VACCINATION SITE WARMTH (Local fever sensation at the vaccination site), VACCINATION SITE IRRITATION (Irritation at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site). At the time of the report, VACCINATION SITE INFLAMMATION (Inflammation at the vaccination site), VACCINATION SITE WARMTH (Local fever sensation at the vaccination site), VACCINATION SITE IRRITATION (Irritation at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-068484 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068484:husband case
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nasal congestion
Clinical narrative: nose a little stuffy; throat a little sore; feeling tired; fever; chills; headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nose a little stuffy), OROPHARYNGEAL PAIN (throat a little sore), FATIGUE (feeling tired), PYREXIA (fever) and CHILLS (chills) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced NASAL CONGESTION (nose a little stuffy), OROPHARYNGEAL PAIN (throat a little sore), FATIGUE (feeling tired), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches). On 06-Apr-2021, NASAL CONGESTION (nose a little stuffy) and OROPHARYNGEAL PAIN (throat a little sore) had resolved. At the time of the report, FATIGUE (feeling tired), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-068508 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068508:CROSS LINKED WITH DOSE 1